ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Health Care

Blood plasma treatment for coronavirus set for Japan trial

Procedure pioneered by 19th century Japanese doctor already approved in US

Frozen plasma taken from blood donations is stored in Bern, Switzerland. Treatments with plasma have long been shown to help fight some infectious diseases.   © Reuters

TOKYO -- Japan will begin a clinical trial of a blood plasma treatment for coronavirus patients as early as this month, joining the U.S., Canada and China in experimenting with the century-old treatment.

The treatment involves infusing into patients blood plasma harvested from those who have recovered from COVID-19, the disease caused by the new coronavirus. Such infusions are hoped to contain antibodies that fight against the virus.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more